Neurologic complications in children under five years with sickle cell disease

Aisha A Galadanci1, Michael R DeBaun2, Najibah A Galadanci3

  • 1Department of Hematology and Blood Transfusion, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.

Insights

Neurologic complications, including silent cerebral infarct and cognitive impairment, are common in children under five with Sickle Cell Disease (SCD). Identifying and managing modifiable risk factors is crucial for preventing brain dysfunction in these young patients.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Global Health

Background:

  • Sickle Cell Disease (SCD) is a prevalent global genetic disorder impacting multiple organs.
  • Preventing end-organ dysfunction, especially in the brain, is a significant challenge in managing pediatric SCD.
  • Neurologic complications are frequent in children under five with SCD, including stroke, epilepsy, and encephalopathy.

Purpose of the Study:

  • To review neurologic complications in children under five with SCD.
  • To describe modifiable risk factors for these complications.
  • To highlight differences in high versus low resource settings.

Main Methods:

  • Literature search of the PubMed database.
  • Utilized Medical Subject Headings (MeSH) and keywords.
  • Focused on articles concerning neurologic complications in children under five with SCD.

Main Results:

  • Silent cerebral infarct and cognitive impairment are the most common neurologic complications in young children with SCD.
  • Neurologic complications may be underreported in this age group.
  • Modifiable risk factors and disparities between resource settings were examined.

Conclusions:

  • Neurologic complications in children under five with SCD are common and potentially underdiagnosed.
  • Silent cerebral infarct and cognitive impairment are key concerns.
  • Addressing modifiable risk factors is essential for improving outcomes in pediatric SCD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
745
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
818
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266